×
About 9,123 results

ALLMedicine™ Barrett's Esophagus Center

Research & Reviews  4,431 results

Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progressio...
https://doi.org/10.14309/ctg.0000000000000244
Clinical and Translational Gastroenterology; Frei NF, Konte K et. al.

Oct 27th, 2020 - An automated risk prediction assay has previously been shown to objectively identify patients with nondysplastic Barrett's esophagus (NDBE) who are at increased risk of malignant progression. To evaluate the predictive performance of the assay in ...

Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A L...
https://doi.org/10.14309/ctg.0000000000000260
Clinical and Translational Gastroenterology; Peters Y, Siersema PD

Oct 26th, 2020 - As novel, less invasive (non)endoscopic techniques for detection of Barrett's esophagus (BE) have been developed, there is now renewed interest in screening for BE and related neoplasia. We aimed to determine public preferences for esophageal aden...

Barretts Esophagus and Esophageal Adenocarcinoma Biomarkers.
https://doi.org/10.1158/1055-9965.EPI-20-0223
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology; Grady WM, Yu M et. al.

Oct 23rd, 2020 - Esophageal adenocarcinoma (EAC) is a major cause of cancer related morbidity and mortality in Western countries. The incidences of EAC and its precursor Barrett's esophagus (BE) have increased substantially in the last four decades. Current care g...

Effect of Roux-en-Y gastric bypass on Barrett's esophagus: a systematic review.
https://doi.org/10.1016/j.soard.2020.09.003
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery; Goonawardena J, Ward S

Oct 21st, 2020 - Roux-en-Y gastric bypass (RYGB) has been recommended as the bariatric procedure of choice for morbidly obese patients with Barrett's esophagus (BE). To systematically review the effect of RYGB on BE. University hospital, Melbourne, Australia. A sy...

Dietary Habits and Risk of Esophagitis and Barrett's Esophagus: A Multicenter Italian C...
https://doi.org/10.1007/s10620-020-06658-9
Digestive Diseases and Sciences; Filiberti RA, Fontana V et. al.

Oct 19th, 2020 - Barrett's esophagus (BE) and esophagitis share potentially modifiable risk factors such as obesity, smoking, and alcohol. The role of diet on BE and esophagitis is still debated. The objective of this study was to examine the association between s...

see more →

Guidelines  25 results

AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dyspla...
https://doi.org/10.1053/j.gastro.2019.09.051
Gastroenterology Sharma P, Shaheen NJ et. al.

Nov 15th, 2019 - The purpose of this best practice advice article is to describe the role of Barrett's endoscopic therapy (BET) in patients with Barrett's esophagus (BE) with dysplasia and/or early cancer and appropriate follow-up of these patients. The best pract...

ASGE guideline on screening and surveillance of Barrett's esophagus.
https://doi.org/10.1016/j.gie.2019.05.012
Gastrointestinal Endoscopy; , Qumseya B et. al.

Aug 23rd, 2019 - ASGE guideline on screening and surveillance of Barrett's esophagus.|2019| ,Qumseya B,Sultan S,Bain P,Jamil L,|diagnosis,pathology,diagnosis,pathology,diagnosis,pathology,

Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplas...
https://doi.org/10.1016/j.gie.2017.10.011
Gastrointestinal Endoscopy; , Wani S et. al.

Feb 5th, 2018 - Endoscopic eradication therapy for patients with Barrett's esophagus-associated dysplasia and intramucosal cancer.|2018| ,Wani S,Qumseya B,Sultan S,Agrawal D,|complications,diagnosis,pathology,surgery,etiology,surgery,

Endoscopic eradication therapy for patients with Barrett’s esophagus–associated dysplasia an...
https://www.asge.org/docs/default-source/education/practice_guidelines/piis0016510717324082.pdf?sfvrsn=0
Sachin Wani

Feb 2nd, 2018 - Barrett’s esophagus (BE) is defined by the replacement of the normal squamous epithelium of the distal esophagus with metaplastic intestinal-type columnar epithelium. 1, 2, 3 BE is an adverse event of chronic GERD and the only identifiable premalig.

Development of quality indicators for endoscopic eradication therapies in Barrett’s esophagu...
https://www.asge.org/docs/default-source/education/practice_guidelines/piis0016510717301906.pdf?sfvrsn=2
Sachin Wani

May 29th, 2017 - The objective of this study was to use a methodologically rigorous process to develop valid quality indicators for EET in the management of patients with BE-related neoplasia. Defining quality indicators has the potential to optimize the managemen.

see more →

Clinicaltrials.gov  4,513 results

Independent Validation of a Tissue Systems Pathology Assay to Predict Future Progressio...
https://doi.org/10.14309/ctg.0000000000000244
Clinical and Translational Gastroenterology; Frei NF, Konte K et. al.

Oct 27th, 2020 - An automated risk prediction assay has previously been shown to objectively identify patients with nondysplastic Barrett's esophagus (NDBE) who are at increased risk of malignant progression. To evaluate the predictive performance of the assay in ...

Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A L...
https://doi.org/10.14309/ctg.0000000000000260
Clinical and Translational Gastroenterology; Peters Y, Siersema PD

Oct 26th, 2020 - As novel, less invasive (non)endoscopic techniques for detection of Barrett's esophagus (BE) have been developed, there is now renewed interest in screening for BE and related neoplasia. We aimed to determine public preferences for esophageal aden...

Barretts Esophagus and Esophageal Adenocarcinoma Biomarkers.
https://doi.org/10.1158/1055-9965.EPI-20-0223
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology; Grady WM, Yu M et. al.

Oct 23rd, 2020 - Esophageal adenocarcinoma (EAC) is a major cause of cancer related morbidity and mortality in Western countries. The incidences of EAC and its precursor Barrett's esophagus (BE) have increased substantially in the last four decades. Current care g...

Effect of Roux-en-Y gastric bypass on Barrett's esophagus: a systematic review.
https://doi.org/10.1016/j.soard.2020.09.003
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery; Goonawardena J, Ward S

Oct 21st, 2020 - Roux-en-Y gastric bypass (RYGB) has been recommended as the bariatric procedure of choice for morbidly obese patients with Barrett's esophagus (BE). To systematically review the effect of RYGB on BE. University hospital, Melbourne, Australia. A sy...

Dietary Habits and Risk of Esophagitis and Barrett's Esophagus: A Multicenter Italian C...
https://doi.org/10.1007/s10620-020-06658-9
Digestive Diseases and Sciences; Filiberti RA, Fontana V et. al.

Oct 19th, 2020 - Barrett's esophagus (BE) and esophagitis share potentially modifiable risk factors such as obesity, smoking, and alcohol. The role of diet on BE and esophagitis is still debated. The objective of this study was to examine the association between s...

see more →

News  131 results

Obesity Linked to Poor Outcomes in UC: Gastro Endo News Report
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/77579

Jan 23rd, 2019 - Obese patients with ulcerative colitis may experience worse outcomes compared with their normal-weight peers, a new study found. In this Q&A, Carl V. Crawford, MD, explores the level of diversity in the field of gastroenterology and how institutio...

Antiplatelet Drugs Reduce Risk of Liver Fibrosis: Gastro Endo News Report
https://www.medpagetoday.com/gastroenterology/generalgastroenterology/76040

Oct 31st, 2018 - A recent study found that antiplatelet drugs may reduce the presence of liver fibrosis in patients with cardiovascular conditions. People swallow the darnedest things. Gastroenterologists share some of their experiences, which include a patient th...

What's Hot at the ACG 2018
https://www.medscape.com/viewarticle/902753

Sep 30th, 2018 - PHILADELPHIA — Preliminary results from a trial of rectal indomethacin dose escalation for the prevention of endoscopic retrograde cholangiopancreatography-related pancreatitis and results from a study of a low-FODMAP diet to reduce symptoms in pa...

Barrett's Tied to Better Survival in Esophageal Ca
https://www.medpagetoday.com/hematologyoncology/othercancers/74954

Sep 6th, 2018 - The presence or absence of gross Barrett's esophagus and/or intestinal metaplasia (BE/IM) had an impact on survival in esophageal adenocarcinoma (EAC), in findings from two independent patient cohorts. Patients with BE/IM presented at earlier stag...

OncoBreak: More News, Developments from ASCO
https://www.medpagetoday.com/hematologyoncology/othercancers/73358

Jun 6th, 2018 - The just-completed American Society of Clinical Oncology meeting included abstracts of almost 6,000 studies. As a supplement to MedPage Today's coverage of the meeting, this week's OncoBreak is devoted to other studies from ASCO with potential to ...

see more →

Patient Education  23 results see all →